24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Omnix Medical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:21
Palantir's AI battlefield software fuels another surge in revenue expectations
10:07
The price of false alarms: How Trump's Iran threats are draining Israel's defense budget
09:52
Monday seeks to double CEO pay weeks after announcing 620 layoffs
09:40
Maor Shlomo's Base44 payday climbs to $150 million after latest Wix payout
More stories
Buzz
Most popular
Daily
Weekly
1
Salesforce veterans raise $20 million pre-Seed from Marc Benioff and Michael Dell to tackle AI’s enterprise bottleneck
2
Billionaire Beny Steinmetz challenges $1.4 million tax demand over $9 million Israeli home sale
3
Deel acquires Israeli deepfake security startup Clarity in $40-50 million deal
4
Visa acquires Israeli fraud prevention company BioCatch for $2.4 billion
5
Israel searches for technology that could find soldiers and pilots who cannot call for help
More news
Omnix Medical
4 stories about Omnix Medical
EU backs Israeli antibiotic developer with €8 million grant to combat deadly superbugs
13.07.26
|
CTech
Omnix Medical will lead a European consortium aimed at accelerating late-stage development of its experimental treatment for drug-resistant hospital infections.
Omnix Medical raises $25 million Series C to tackle drug-resistant infections
15.10.25
|
CTech
Israeli biotech secures funding to complete Phase II trials for its novel antimicrobial peptide therapy.
Israeli biopharma startup Omnix Medical awarded €10.8 million from EU to fight drug-resistant bacteria
26.01.21
|
Meir Orbach
The novel agents developed by Omnix are designed as an alternative to classical antibiotics
Omnix Medical completes $8.5 million round to develop next-generation antibiotics for treatment of life-threatening infections
03.11.20
|
Meir Orbach
The Israeli startup has successfully completed testing in animals and the new funding will allow it to begin clinical trials with humans